Details
Category: Volume 07 Issue 07 July 2019
Hits: 1067

Title: Seroprevalence of HIV, HbsAg & HCV infections in voluntary blood donors in a hospital based blood bank

Authors; Dr Kavatkar Anita N, Dr Taksande Rahul V., Dr Agrawal Sugam, Dr Lanjewar D.N.

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.07

Abstract

Background: Transfusion transmitted infections are one of the concerning risks of blood transfusion which must be eliminated as far as possible.

Aim: The study was undertaken to find out the prevalence and trends of HIV, HBsAg and HCV infections over 9 years from 2009 to 2017, among voluntary blood donors in a blood bank at a tertiary care hospital.

Methods: 9 years retrospective study of data from blood bank.

Inclusion criteria: All blood units that have tested positive for HIV, HBsAg, HCV.

Exclusion criteria: All blood units that have tested negative for HIV, HBsAg, HCV.

Data from 2009 to 2017 was studied for prevalence of HIV, HBsAG and HCV infections among voluntary blood donors.

Blood samples were collected from donor blood bags in plain vacutainers and tested for anti HIV, HBsAg and anti HCV for all samples by commercial Enzyme Linked Immunoassay technique (3rd generation Enzyme Linked Immunoassay kits). Percentage of reactive samples for all three markers was calculated.

Results: Overall positivity for all three markers was 3.67%. HBsAg showed highest average seroprevalence among the three markers (1.81%) followed by anti HCV (1.08%) and anti HIV (0.78%). Anti HIV prevalence increased gradually from 0.58% in 2009 to 1.08% in 2017 except for a peak in 2011 when the prevalence was the highest at 1.5% . The highest prevalence for HBsAg was seen in the year 2012 (2.27%). The prevalence of anti HCV was highest in 2013 (1.77%) and lowest in 2015 (0.08%).

Conclusions: A greater average seroprevalence was noted for HBsAg. The levels of HBsAgand anti HCV continue to be high in India.

Keywords: Seroprevalence, blood donors, anti HIV, HBsAg, HCV.

References

  1. Ward JW, Deppe DA, Samson S, Perkins H, Holland P, Fernando L, et al. Risk of HIV infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:61-2.
  2. Hollan SR, Wagstaff W, Leikola J, Lothe F. Management of blood transfusion services, Geneva: World Health Organization; 1990. p. 131.
  3. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India: HIV/AIDS Epidemi-ological Surveillance & Estimation Report for the year 2005. Available from <http://www.nacoonline.org/fnlapi06rpt.pdf>
  4. Panigrahi AK, Panda SK, Dixit RK. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol 1997;5:167–
  5. Randell RL, HollandPV. Transfusion associated hepatitis. In: SarinSK, HessG, eds. Transfusion Associated Hepatitis: Diagnosis, Treatment and Prevention. CBS Publications: New Delhi, 1997:115–
  6. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections.The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-1690.
  7. Kiran V. Hepatitis B vaccine introduction into the routine immunization schedule – Andhra Pradesh experience. Indian J Public Health. 2004;48:63-66.
  8. Chandra T, Kumar A, Gupta A (2009) Prevalence of transfusion transmitted infections in blood donors: an Indian experience.TropDoct 39:152–154 Indian J Hematol Blood Transfus (Jan-Mar 2011) ;27(1):1–6 5.
  9. Pahuja S, Sharma M, Baitha B, Jain M (2007) Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors. A hospitalbased study. Jpn J Inf Dis; 60:389–391.
  10. Sidhu M, Kotwal U, Kapoor R, Raina T. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in blood donors of Jammu Province: A tertiary care centre experience.Asian J Transfus Sci. 2013;7(2)162-3.
  11. Shah N, Shah JM, Jhaveri P, Patel K, Shah CK, Shah NR. Seroprevalence of HBV, HCV, HIV and syphilis among blood donors at a tertiary care teaching hospital in Western India. Gujarat Medical Journal. 2013;68(2)35-9.
  12. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: Exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13(27):3730-3.
  13. Suresh B., Shreedhar KV, Venkataramana B. et al. Burden of transfusion transmissible viral infections among blood donors at a tertiary care referral teaching hospital in South India. Journal of Clinical and Scientific Research. 2016;5(3):160-3.
  14. Pandey A, Sahu D, Bakkali T, Reddy D, Venkatesh S, Bhattacharya M et al. Estimate of HIV prevalence and number of people living with HIV in India 2008-2009. Br Med J.2012;2(5).
  15. Deshpande R, Bhosale S, Gadgil PA, Sonawane M. Blood donor’s status of HIV, HBV, HCV and syphilis in this region of Marathwada, India. Journal of Krishna Institute of Medical Sciences University. 2012;1(2):111-6.
  16. Chougale RA, Shinde PJ. Seroprevalence of transfusion transmitted infections among voluntary blood donors at a tertiary care teaching hospital in Kolhapur, India. International Journal of Recent trends in Science and Technology.2017;22(1)01-06.
  17. Screening donated blood for transfusion transmissible infections.Geneva:World Health Organisation;2010:67.
  18. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999; 353: 359-363.
  19. Margaritis AR, Brown SM, Seed CR, Kiely P, D’Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007; 47: 1783-1793.
  20. Snyder EL, Dodd RY: Reducing the risk of blood transfusion. Hematology (Am SocHematolEduc Program) 2001:433-442.
  21. Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol. 2015;7(3):600-06.
  22. Bihl F, Castelli D, Marincola F, Dodd R, Brander C. Transfusion transmitted infections. Journal of Translational Medicine. 2007;5:25.

Corresponding Author

Dr Anita N Kavatkar

Department of Pathology (blood bank), Sir J J Hospital and Grant Medical College, Byculla,

Mumbai 400008, India